At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
Continuous Positive Airway Pressure (CPAP)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients: A Randomized Clinical Trial
In Brief
A clinical study evaluating Continuous Positive Airway Pressure (CPAP) for Sleep Apnea, Obstructive and Heart Failure. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The study aimed to examine the effect of Continuous Positive Airway Pressure (CPAP) initiation for newly diagnosed obstructive sleep apnea (OSA) in hospitalized heart failure patients on reducing 30-day hospital readmission rate through a clinical trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Apnea, Obstructive, Heart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedFeb 2017
Primary CompletionDec 2017
TodayJul 2026
First PostedFeb 17, 2017
Enrollment StartFeb 8, 2016
Primary CompletionDec 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.4 years ago
Interventions
Continuous Positive Airway Pressure (CPAP)device
The auto-CPAP group will be scheduled for follow-up with a phone call at 2 - 3 weeks post discharge, then in sleep medicine clinic at 1 month (+2 weeks) and 6 months (+2 weeks) to assess their progress on CPAP.